In this issue:
Anti-PD-1 therapy in advanced melanoma and preexisting autoimmunity or ipilimumab-triggered autoimmunity:
A German study
Anti-PD-1 therapy in advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab: An international study
Safety profile of nivolumab monotherapy for advanced melanoma
High-dose interferon-α-2b in stage T2bNO, T3a-bNO, T4a-bNO, and T1-4N1a-2a (microscopic) melanoma
HRQoL with adjuvant ipilimumab vs placebo after complete resection of high-risk stage III melanoma
Clinical course and patterns of metastases of mucosal melanomas
Tumour thickness and mitotic rate predict OS in patients with PVM
GEP improves dentification of high-risk cutaneous melanoma tumours
UDN as a major factor of efficiency in melanoma detection
EIS in short-term digital dermoscopy imaging of melanocytic lesions
Please login below to download this issue (PDF)